Ignite Creation Date:
2025-12-24 @ 11:46 PM
Ignite Modification Date:
2026-05-19 @ 9:08 PM
Study NCT ID:
NCT00160251
Status:
COMPLETED
Last Update Posted:
2015-10-14
First Post:
2005-09-08
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Boceprevir (SCH 503034) Plus Peg-Intron, With and Without Added Ribavirin, in Patients With Chronic Hepatitis C, Genotype 1, Who Did Not Respond to Previous Treatment With Peginterferon Alfa Plus Ribavirin (Study P03659AM2)(COMPLETED)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
P03659
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None